CompletedPhase 4

Relative Potency of Inhaled Corticosteroids

Canada40 participantsStarted 2001-01

Plain-language summary

To investigate the validity of a clinical model to determine the relative potency of different preparations of inhaled corticosteroids used for the treatment of asthma or of eosinophilic bronchitis without asthma.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Recent asthma or COPD exacerbation (as judged by the clinician) due to respiratory infection within the last month
✕. Relevant seasonal allergen exposure within 4 weeks or within the course of the study
✕. Treatment with prednisone or antibiotics or hospitalisation within the past 6 weeks
✕. Other respiratory diseases
✕. Women who are pregnant or unwilling to use appropriate contraception during the study
✕. Unable to withhold short-acting ß-agonist treatment for 6 hours before visit

What they're measuring

Sputum eosinophils

Trial details

NCT IDNCT00292838

SponsorSt. Joseph's Healthcare Hamilton

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2007-02

View on ClinicalTrials.gov More Asthma trials